We serve Chemical Name:2-bromo-1-(5-fluoro-2-hydroxyphenyl)ethanone CAS:126581-65-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-bromo-1-(5-fluoro-2-hydroxyphenyl)ethanone
CAS.NO:126581-65-5
Synonyms:2-Bromo-5′-fluoro-2′-hydroxyacetophenone;2-bromo-1-(5-fluoro-2-hydroxyphenyl)-1-ethanone;Ethanone,2-bromo-1-(5-fluoro-2-hydroxyphenyl);5-Fluoro-2-hydroxyphenacyl bromide;MFCD03094564
Molecular Formula:C8H6BrFO2
Molecular Weight:233.03400
HS Code:2914700090
Physical and Chemical Properties:
Melting point:87-91ºC
Boiling point:290.6ºC at 760mmHg
Density:1.703g/cm3
Index of Refraction:1.585
PSA:37.30000
Exact Mass:231.95400
LogP:2.10890
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3335
Packing Group:
Contact us for information like 2-Bromo-5′-fluoro-2′-hydroxyacetophenone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD03094564 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-bromo-1-(5-fluoro-2-hydroxyphenyl)-1-ethanone Use and application,2-bromo-1-(5-fluoro-2-hydroxyphenyl)-1-ethanone technical grade,usp/ep/jp grade.
Related News: Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition. 2-bromo-1-(5-fluoro-2-hydroxyphenyl)ethanone manufacturer However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. 2-bromo-1-(5-fluoro-2-hydroxyphenyl)ethanone supplier However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. 2-bromo-1-(5-fluoro-2-hydroxyphenyl)ethanone vendor However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. 2-bromo-1-(5-fluoro-2-hydroxyphenyl)ethanone factory Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.